Lite Strategy, Inc. Other Nonoperating Expense
Lite Strategy, Inc. (LITS) reported Other Nonoperating Expense of $5.00 thousand for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2020-11-10
- Lite Strategy, Inc. other nonoperating expense for the quarter ending 2020-09-30 was $5.00K, a 64.29% decline year-over-year.
- Lite Strategy, Inc. other nonoperating expense for the quarter ending 2019-09-30 was $14.00K, a 1300.00% increase year-over-year.
- Lite Strategy, Inc. other nonoperating expense for the quarter ending 2018-09-30 was $1.00K.
| Period end | Other Nonoperating Expense 3 month |
|---|---|
| 2020-09-30 | $5.00K 10-Q · filed 2020-11-10 |
| 2019-09-30 | $14.00K 10-Q · filed 2020-11-10 |
| 2018-09-30 | $1.00K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |